Gemcitabine Supplier-Buyer Network — Trade Flow Analysis

Name: Gemcitabine Supplier-Buyer Trade Network Dataset — 248+ Indian Exporters, 20+ Importers, 125+ Countries (DGFT 2022–2026)
Creator: TransData Nexus
License: https://transdatanexus.com/terms
Keywords: Gemcitabine supplier network, Gemcitabine buyers, pharmaceutical export India, Gemcitabine trade data

TransData Nexus

Gemcitabine

India Pharmaceutical Trade Intelligence

$46.5M248 Suppliers125 CountriesHS 30049049

ExportsIndia → UNITED STATES16.8%India → BELGIUM12.7%

ImportsUNITED STATES → India$133.8M FRANCE → India$35.5M

#1 Supplier: FRESENIUS KABI #1 Buyer: YUSEN LOGISTICS

Who Supplies Gemcitabine? Top Manufacturers & Buyers 2026 — FRESENIUS KABI ONCOLOGY LIMITED Leads | TransData Nexus | TransData Nexus

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the first-largest Gemcitabine exporter from India, with a market share of 10.0% and a total export value of $4.6M across 137 shipments. Their average shipment value of $33.9K is above the market average of $15.8K, suggesting premium or bulk contract pricing.

SUN PHARMACEUTICAL INDUSTRIES LIMITED serves 5 named buyers in our database. YUSEN LOGISTICS BENELUX BELGIUM is the dominant customer, accounting for 85.6% of this supplier's tracked business. Top customers include:

• YUSEN LOGISTICS BENELUX BELGIUM — $4.0M across 117 shipments (85.6% of this supplier's total exports)

• YUSEN LOGISTICS BENELUX BELGIUM — $351.3K across 10 shipments (7.6% of this supplier's total exports)

• KEETBERGLAAN 2 — $141.1K across 4 shipments (3.0% of this supplier's total exports)

• M/S. SUN PHARMACEUTI — $130.9K across 4 shipments (2.8% of this supplier's total exports)

• SUN PHARMACEUTICALS — $44.9K across 1 shipments (1.0% of this supplier's total exports)

Key Insight: SUN PHARMACEUTICAL INDUSTRIES LIMITED's per-shipment value of $33.9K is 114% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.

2EUGIA PHARMA SPECIALITIES LIMITED

EUGIA PHARMA SPECIALITIES LIMITED is the second-largest Gemcitabine exporter from India, with a market share of 6.1% and a total export value of $2.8M across 188 shipments. Their average shipment value of $15.0K is below the market average of $15.8K, reflecting a high-volume, competitive pricing strategy.

EUGIA PHARMA SPECIALITIES LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EUGIA PHARMA (MALTA) LTD, — $1.1M across 73 shipments (39.1% of this supplier's total exports)

• APL SWIFT SERVICES (MALTA) LTD., — $631.4K across 42 shipments (22.4% of this supplier's total exports)

• EUGIA PHARMA MALTA L — $380.2K across 25 shipments (13.5% of this supplier's total exports)

• AUROVIDA FARMACEUTIC — $366.4K across 24 shipments (13.0% of this supplier's total exports)

• APL SWIFT SERVICES (MALTA) LTD., — $342.6K across 23 shipments (12.1% of this supplier's total exports)

Key Insight: EUGIA PHARMA SPECIALITIES LIMITED operates with high shipment frequency (188 shipments) at a per-shipment value of $15.0K, indicating a broad distribution network with many smaller, regular orders.

3FRESENIUS KABI ONCOLOGY LIMITED

FRESENIUS KABI ONCOLOGY LIMITED is the third-largest Gemcitabine exporter from India, with a market share of 6.0% and a total export value of $2.8M across 339 shipments. Their average shipment value of $8.2K is below the market average of $15.8K, reflecting a high-volume, competitive pricing strategy.

FRESENIUS KABI ONCOLOGY LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• FRESENIUS KABI DEUTSCHLAND GMBH — $1.2M across 142 shipments (42.0% of this supplier's total exports)

• FRESENIUS KABI (THAILAND) LTD — $495.5K across 61 shipments (17.9% of this supplier's total exports)

• FRESENIUS KABI THAIL — $408.4K across 50 shipments (14.7% of this supplier's total exports)

• FRESENIUS KABI (THAILAND) LTD — $370.1K across 45 shipments (13.3% of this supplier's total exports)

• FRESENIUS KABI MALAYSIA SDN BHD — $334.9K across 41 shipments (12.1% of this supplier's total exports)

Key Insight: FRESENIUS KABI ONCOLOGY LIMITED operates with high shipment frequency (339 shipments) at a per-shipment value of $8.2K, indicating a broad distribution network with many smaller, regular orders.

4MYLAN LABORATORIES LIMITED

MYLAN LABORATORIES LIMITED is the fourth-largest Gemcitabine exporter from India, with a market share of 5.8% and a total export value of $2.7M across 32 shipments. Their average shipment value of $85.0K is above the market average of $15.8K, suggesting premium or bulk contract pricing.

MYLAN LABORATORIES LIMITED serves 2 named buyers in our database. MYLAN INSTITUTIONAL INC is the dominant customer, accounting for 54.1% of this supplier's tracked business. Top customers include:

• MYLAN INSTITUTIONAL INC — $1.5M across 17 shipments (54.1% of this supplier's total exports)

• MYLAN INSTITUTIONAL INC — $1.2M across 15 shipments (45.9% of this supplier's total exports)

Key Insight: MYLAN LABORATORIES LIMITED's per-shipment value of $85.0K is 437% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.

5ACCURE LABS PRIVATE LIMITED

ACCURE LABS PRIVATE LIMITED is the fifth-largest Gemcitabine exporter from India, with a market share of 5.8% and a total export value of $2.7M across 107 shipments. Their average shipment value of $25.2K is above the market average of $15.8K, suggesting premium or bulk contract pricing.

ACCURE LABS PRIVATE LIMITED serves 5 named buyers in our database. PHARMACIE CENTRALE DES HOPITAUX is the dominant customer, accounting for 65.1% of this supplier's tracked business. Top customers include:

• PHARMACIE CENTRALE DES HOPITAUX — $1.8M across 70 shipments (65.1% of this supplier's total exports)

• To The Order — $322.1K across 13 shipments (12.0% of this supplier's total exports)

• NA — $293.4K across 12 shipments (10.9% of this supplier's total exports)

• BANQUE POPULAIRE BPC — $178.2K across 7 shipments (6.6% of this supplier's total exports)

• CREDIT IMMOBILIER ET — $146.2K across 6 shipments (5.4% of this supplier's total exports)

Key Insight: ACCURE LABS PRIVATE LIMITED's per-shipment value of $25.2K is 59% above the market average of $15.8K, consistent with large-order contracts or value-added formulations.

6INTAS PHARMACEUTICALS LIMITED

INTAS PHARMACEUTICALS LIMITED is the fifth-largest Gemcitabine exporter from India, with a market share of 3.7% and a total export value of $1.7M across 231 shipments. Their average shipment value of $7.4K is below the market average of $15.8K, reflecting a high-volume, competitive pricing strategy.

INTAS PHARMACEUTICALS LIMITED serves 5 named buyers in our database. Business is spread across multiple buyers, reducing single-customer dependency. Top customers include:

• EVERSANA LIFE SCIENCES SERVICES,LLC — $677.8K across 91 shipments (39.5% of this supplier's total exports)

• AMERISOURCE HEALTH SERVICES — $342.7K across 46 shipments (20.0% of this supplier's total exports)

• EVERSANA LIFE SCIENCES SERVICES,LLC — $325.1K across 44 shipments (18.9% of this supplier's total exports)

• ACCORD HEALTHCARE C/ — $198.1K across 27 shipments (11.5% of this supplier's total exports)

• XXCORXXHEAXXHCAXX B — $173.8K across 23 shipments (10.1% of this supplier's total exports)

Key Insight: INTAS PHARMACEUTICALS LIMITED operates with high shipment frequency (231 shipments) at a per-shipment value of $7.4K, indicating a broad distribution network with many smaller, regular orders.

1United States

United States ranks as the first-largest destination for Gemcitabine imports from India, with a total trade value of $7.8M across 47 shipments — representing a 16.8% share of all Gemcitabine exports. The average shipment value of $166.1K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 4 tracked buyers.

Named Gemcitabine importers in United States: MYLAN INSTITUTIONAL INC 2898 is the largest buyer, accounting for 31.5% ($2.5M) of this market's total imports.

• MYLAN INSTITUTIONAL INC 2898 — $2.5M (31.5% of United States's total)

• MYLAN INSTITUTIONAL INC — $1.2M (16.0% of United States's total)

• EVERSANA LIFE SCIENCES SERVICES,LLC — $946.8K (12.1% of United States's total)

Key Insight: United States's per-shipment average of $166.1K (949% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

United States is a key market for Gemcitabine imports from India.

Primary Market

Secondary Market

2Belgium

Belgium ranks as the second-largest destination for Gemcitabine imports from India, with a total trade value of $5.9M across 116 shipments — representing a 12.7% share of all Gemcitabine exports. The average shipment value of $50.9K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 1 tracked buyer.

Named Gemcitabine importers in Belgium: YUSEN LOGISTICS BENELUX BELGIUM is the largest buyer, accounting for 85.9% ($5.1M) of this market's total imports.

• YUSEN LOGISTICS BENELUX BELGIUM — $5.1M (85.9% of Belgium's total)

Key Insight: Belgium's per-shipment average of $50.9K (221% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Belgium is a key market for Gemcitabine imports from India.

Primary Market

Secondary Market

3Malta

Malta ranks as the third-largest destination for Gemcitabine imports from India, with a total trade value of $5.4M across 142 shipments — representing a 11.6% share of all Gemcitabine exports. The average shipment value of $38.2K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Gemcitabine importers in Malta: EUGIA PHARMA (MALTA) LTD, is the largest buyer, accounting for 62.2% ($3.4M) of this market's total imports.

• EUGIA PHARMA (MALTA) LTD, — $3.4M (62.2% of Malta's total)

• APL SWIFT SERVICES (MALTA) LTD., — $631.4K (11.7% of Malta's total)

Key Insight: Malta's per-shipment average of $38.2K (141% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Malta is a key market for Gemcitabine imports from India.

Primary Market

Secondary Market

4Algeria

Algeria ranks as the fourth-largest destination for Gemcitabine imports from India, with a total trade value of $3.5M across 87 shipments — representing a 7.6% share of all Gemcitabine exports. The average shipment value of $40.6K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 2 tracked buyers.

Named Gemcitabine importers in Algeria: PHARMACIE CENTRALE DES HOPITAUX is the largest buyer, accounting for 59.5% ($2.1M) of this market's total imports.

• PHARMACIE CENTRALE DES HOPITAUX — $2.1M (59.5% of Algeria's total)

• SPA IMGSA GROUPE INSDUSTRIES — $748.4K (21.2% of Algeria's total)

Key Insight: Algeria's per-shipment average of $40.6K (156% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Algeria is a key market for Gemcitabine imports from India.

Primary Market

Secondary Market

5Russia

Russia ranks as the fifth-largest destination for Gemcitabine imports from India, with a total trade value of $2.9M across 23 shipments — representing a 6.3% share of all Gemcitabine exports. The average shipment value of $126.6K is above the global average of $15.8K, indicating high-value procurement contracts or branded formulations. This market is served by 3 tracked buyers.

Named Gemcitabine importers in Russia: OOO JODAS EXPOIM is the largest buyer, accounting for 40.9% ($1.2M) of this market's total imports.

• OOO JODAS EXPOIM — $1.2M (40.9% of Russia's total)

• OOOJODAS EXPOIM — $677.7K (23.3% of Russia's total)

• OOO"JODAS EXPOIM" — $481.1K (16.5% of Russia's total)

Key Insight: Russia's per-shipment average of $126.6K (699% above global average) points to a market favouring large-batch or high-value pharmaceutical procurement.

Russia is a key market for Gemcitabine imports from India.

Primary Market

Secondary Market

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Network Construction: Supplier-to-buyer trade relationships constructed from verified shipment pairs in Indian Customs (DGFT) records for Gemcitabine.
2.Flow Mapping: 248 Indian manufacturers mapped to their international buyer networks using consignee name normalization.
3.Value Aggregation: Trade value per supplier-buyer link aggregated from 2,938 individual shipment records. Values are FOB in USD.
4.Geographic Clustering: Buyer networks clustered across 125 destination countries to identify geographic concentration patterns.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

2,938 Verified Shipments

248 manufacturers in network

Expert-Reviewed

By pharmaceutical trade specialists

Gemcitabine

Gemcitabine

Who Supplies Gemcitabine? Top Manufacturers & Their Global Buyers

🏭 Market Analysis: Top Suppliers & Customer Networks

Market Intelligence

Official References & Regulatory Resources

Who Supplies Gemcitabine? Top Manufacturers & Their Buyers

Supplier-Customer Network Analysis

Gemcitabine Supplier Network — Key Market Intelligence

Market Analysis: Top Suppliers & Their Customer Networks

1SUN PHARMACEUTICAL INDUSTRIES LIMITED

2EUGIA PHARMA SPECIALITIES LIMITED

3FRESENIUS KABI ONCOLOGY LIMITED

4MYLAN LABORATORIES LIMITED

5ACCURE LABS PRIVATE LIMITED

6INTAS PHARMACEUTICALS LIMITED

From Indian Factories to Global Pharmacies — How Gemcitabine Flows

🌍 Market Analysis: Top Importing Countries & Importers

Where Does Gemcitabine Go? Top Importing Countries & Their Buyers

Geographic Market Flow Analysis

Market Analysis: Top Importing Countries & Their Importers

1United States

2Belgium

3Malta

4Algeria

5Russia

People Also Ask — Gemcitabine Supplier & Trade Network

Gemcitabine Trade Network — Key Takeaways

Network Overview

Supplier Network

Country Network

Network Insights

Related Analysis

Network Intelligence

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology